Abbreviations: allergic rhinitis (AR), β-hexosaminidase (β-hex), cyclanoline (Cyc), fangchinoline (Fan), hot water extract (HWEx), immunoglobulin E (IgE), L-histidine decarboxylase (HDC), rat basophilic leukemia cell line (RBL-2H3), tetrandrine (Tet), tyrosine (Tyr), We investigated the anti-allergic activities of a hot water extract of Stephania tetrandra S. Moore using RBL-2H3 cells and an allergic rhinitis mouse model. The degranulation levels were significantly lower in the water-solvent fraction (WEx) and 99% ethanol fraction (99% EtEx) extracted from S. tetrandra than in the control. However, the cell viability of 99% EtEx was significantly lower than the control. In an ovalbumin allergic rhinitis mouse model, the frequency of sneezing after the fifth nasal ovalbumin (OVA) challenge in the groups intragastrically administered WEx and 99% EtEx decreased significantly compared to the control, although this decrease was lost following the sixth or seventh challenge. Plasma levels of OVA-specific immunoglobulin E in the WEx and 99% EtEx groups were significantly lower than the control at the experimental end point. Thus, S. tetrandra was proposed to be an effective anti-allergic natural medicine.
Introduction
The number of patients suffering from allergic diseases, such as allergic rhinitis (AR) and conjunctivitis, and allergies against pollen and food is increasing worldwide (Alessandro et al., 2011) .
Allergic responses are classified into various types, such as type I (anaphylactic shock) and type IV (tuberculin reaction). In type I allergic responses, activation of the immunoglobulin E (IgE)-mediated FcεRI receptor, known as the high-affinity IgE receptor, on the plasma membrane of mast and basophilic cells induces the release of β-hexosaminidase (β-hex), a common marker of degranulation, and various allergic mediators, including histamine, cytokines, prostaglandins, and leukotrienes (Amin, 2012) . The cross-linked structure between IgE on FcεRI and the allergen activates Lyn and Fyn, which are part of the Src family of nonreceptor tyrosine kinases. Lyn activation induces phosphorylation of Syk kinase and Ca 2+ mobilization (Metcalfe et al., 2009) . The rat basophilic leukemia cell line, RBL-2H3, has been used to study IgE-FcεRI interactions in the intracellular signaling for degranulation (Passante et al., 2009) . Moreover, RBL-2H3 cells are a useful tool for the in vitro screening of potential anti-allergic compounds. In AR models, BALB/c mice are sensitized with pollen, house dust, ovalbumin (OVA), etc. The AR mouse model induced by OVA is a useful tool for studying the effects of antiallergic compounds in vivo because it exhibits high OVA-specific
IgE levels in plasma with a short sensitization period.
The roots of Stephania tetrandra S. Moore have been widely used in multiple treatments (Ernesto et al., 2007; Sun et al., 2011; Chor et al., 2009; Tsutsumi et al., 2008) . The main active components of S. tetrandra include cyclanoline (Cyc), tetrandrine (Tet), and fangchinoline (Fan). Cyc inhibits acetylcholinesterase (Ingkaninan et al., 2006) , while Tet and Fan are calcium channel blockers (Ernest et al., 2007) . Previous study showed that Tet and Fan inhibit histamine release (Nakamura et al., 1992) . Fan is an inhibitor of L-histidine decarboxylase (HDC), which is an enzyme involved in L-histamine synthesis (Adachi, 2006) . The hot water extract of S. tetrandra suppressed the release of β-hex in RBL-2H3 cells (Asano et al., 2011) . However, Tet and Fan are reported to be only slightly soluble in water (Ernesto et al., 2007) , and until now the water-soluble compounds in S. tetrandra have been overshadowed by the focus on Tet and Fan. Therefore, we speculated that anti-allergic compounds besides Tet and Fan could be found as water-soluble components in the hot water extract of S.
tetrandra.
We investigated the anti-allergic effects of a hot water extract of S. tetrandra using RBL-2H3 cells and an OVA-induced AR mouse model.
Experimental
Sample preparation S. tetrandra was purchased from the national crude drug market in the province of Anhui, China and powdered using a crusher (Retsch, Nissei Co., Tokyo, Japan). The powder was extracted in a 10-fold volume of methanol by sonication for 30 min. After sonication, the solution was mixed for 24 h on a rotary shaker (R-2, Nippon Medical & Chemical Instruments Co., Ltd, Osaka, Japan). Next, the solution was centrifuged for 15 min at 10,000 rpm and 4℃ (Hi mac CR20G, Hitachi Ltd., Tokyo, Japan). The precipitate was dried at room temperature, and then extracted in a 20-fold volume of distilled water by sonication for 30 min. After sonication, the solution was mixed for 24 h with a magnetic stirrer and then incubated in a boiling-water bath for 1 h. After boiling, the solution was centrifuged for 30 min at 15,000 rpm and 4℃, and the supernatant was lyophilized (HWEx; hot water extract).
The HWEx was dissolved in a 20-fold volume of distilled water. The solution was fractionated using a glass column (φ 9. 
Detection of peptides and proteins in the WEx Peptides in
WEx were detected using a BCA protein assay kit (Takara Bio
Inc., Shiga, Japan), while proteins were detected using a CB-X protein assay kit (Takara Bio Inc.).
Cell culture RBL-2H3 cells were obtained from the Health Science Research Resource Bank (Tokyo, Japan). Cells were grown in Eagle's minimum essential medium (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) containing 0.2% NaHCO 3 ,
1.0% penicillin-streptomycin (Nacalai Tesque, Inc., Kyoto, Japan), and 10% fetal calf serum (Corning, Inc., Corning, NY, USA) at 37℃ in a humidified atmosphere of 5% CO 2 .
β-Hex and MTT assays with RBL-2H3 cells
We used β-hex as an index of degranulation. The assay was performed using a previously published method (Asano et al., 2011; Isoda et al., 2012) . RBL-2H3 cells were seeded in 96-well plates at a density of glucopyranoside (Nacalai Tesque, Inc.) in 100 mM citrate buffer, pH 4.5) was added to the supernatants, and the plates were incubated at 37℃ for 30 min. Finally, 100 μL/well of stop buffer (2.0 M glycine buffer, pH 10.4) was added, and the absorbance at 405 nm was determined using a microplate reader (SUNRISE Thermo RC-R, TECAN Ltd., Männedorf, Switzerland).
Cell viability was measured using a MTT assay. After the supernatant from the β-hex assay was removed and washed, 100 μL of 0.5 mg/mL MTT dissolved in medium without phenol red was added to the wells and incubated for 1 h at 37℃ and 5% CO 2 . After incubation, the medium was removed. After 200 μL of dimethyl sulfoxide was added to the wells, the absorbance at 570 nm (650 nm reference absorbance) was determined using a microplate reader (Infinite M200, TECAN Ltd., Männedorf, Switzerland).
AR mouse model and treatment Twenty 6-week-old BALB/c female mice were purchased from Clea Japan (Tokyo, Japan We employed the AR mouse model for this study (Mo et al., 2011) . All mice were sensitized with an intraperitoneal (i.p.)
injection of 100 μL of 1 mg/mL OVA (grade V, Sigma-Aldrich) in saline and 100 μL of aluminum hydroxide gel (Imject™ Alum Adjuvant, Thermo Fisher Scientific Inc., Waltham, MA, USA) on days _ 21 and _ 14. On day _ 7, the boosted sensitization was completed with an i.p. injection of 50 μg of OVA. On day _ 1, we collected mouse plasma, and OVA-specific IgE levels in the plasma were determined in order to confirm OVA sensitization.
Seven days after the booster (day 1), the sensitized mice were divided into four groups of five mice each (Control group, LowWEx treatment group, High-WEx treatment, and 99% EtEx treatment group). After general sensitization, mice were given an intranasal (i.n.) injection of 500 μg of OVA per 10 μL on days 1 to 7 (i.n. challenge). In addition, selected mice were treated by intragastric (i.g.) administration (Control group: 100 μL saline, Low-WEx group: 100 μL of 6 mg/mL WEx, High-WEx group: 100 μL of 12 mg/mL WEx, and 99% EtEx group: 100 μL of 0.5 mg/ mL 99% EtEx) 30 min prior to the i.n. challenge. One mouse each in the control and High-WEx groups died during the i.n. challenge.
We recorded sneezing frequencies for 15 min after the i.n.
challenge. At the experimental end point (day 10: Control group and Low-WEx group, day 11: High-WEx group and 99% EtEx group), mice were euthanized with isoflurane to obtain whole blood and dorsal skin samples.
Vascular permeability
We measured vascular permeability according to a previously published method (Goto et al., 2009 ). Measurement of OVA-specific IgE levels in the plasma We measured the levels of OVA-specific IgE using a capture enzymelinked immunosorbent assay with modifications (Strouse et al., 1991) . Plasma samples were collected at day _ 1 and the end point.
The anti-mouse IgE antibody was purchased from Bethyl Lab, Inc.
(Montgomery, TX, USA), and streptavidin-HRP was purchased from Abcam (Cambridge, UK). The biotinylation of OVA was completed with a biotinylation kit (Sulfo-OSu, Dojindo
Laboratories, Kumamoto, Japan). The levels of OVA-specific IgE were expressed as absorbance values.
Statistical analysis Statistically significant differences in the β-hex assay, MTT assay, vascular permeability, and absorbance of OVA-specific IgE were determined using a one-way ANOVA followed by Dunnett's multiple comparison test. Statistically significant differences in sneezing frequency were determined using a repeated two-way ANOVA followed by Bonferroni's multiple comparison test. P values less than 0.05 were considered significant. GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA) was used for all analyses.
Results

Fractionation and analysis
We subjected HWEx to HP-20 column chromatography using a stepwise EtOH elution method and obtained five fractions: non-adsorbed extract, WEx, 20% EtEx, 50% EtEx, and 99% EtEx. The weights of the extracted fractions from 1 g of HWEx were 480 mg (non-adsorbed extract), 320 mg (WEx), 130 mg (20% EtEx), 50 mg (50% EtEx), and 6 mg (99% EtEx).
We further analyzed the four fractions (WEx, 20% EtEx, 50%
EtEx, and 99% EtEx) using HPLC. Figure 1A shows a typical chromatogram for the Tet reference. The elution time of Tet was approximately 28.5 min (Fig. 1A) . Figure 1B -1E shows the chromatograms for WEx, 20% EtEx, 50% EtEx, and 99% EtEx, respectively. In reference to the previous report (Huang et al., 2006) , it was estimated that the Cyc and Fan peaks occurred at 19 _ 20 and 26 _ 27 min, respectively ( Fig. 1D and 1E ). Based on the chromatograms (Fig. 1B-1E ), Tet and Fan were not present in WEx and 20% EtEx.
HPLC analysis determined that WEx exhibited an absorbance peak at 280 nm; however, it was lower than the other fractions.
Diaion ® HP-20 mainly captures peptides greater than 1 kDa in size, proteins, and polyphenols. Next, we analyzed the presence of peptides and proteins in WEx. In the CB-X assay, absorbance at at 562 nm in the BCA assay was detected in WEx ( Fig. 2A) .
Moreover, WEx showed two spots on the TLC plate after the ninhydrin reaction (Fig. 2B) 
β-Hex and MTT assays We examined the inhibitory effects of HWEx fractions on the degranulation of RBL-2H3 cells in vitro.
Among these fractions, WEx and 99% EtEx showed a concentration-dependent decrease in degranulation (data not shown). The degranulation for 5 mg/mL WEx in a volume of 5 μL was significantly lower than the control (Fig. 3A) . The addition of 5 μL WEx showed the minimum degranulation of 49.8% (Fig. 3A) .
This finding suggests that WEx contains anti-allergic compounds.
The level of degranulation for 0.2 mg/mL 99% EtEx in a volume of 5 μL was significantly lower than the control (Fig. 3B) . However, the cell viability after the addition of 5 μL of 99% EtEx was lower than the control (Fig. 3C) . The degranulation percentage and cell viability after treatment with 99% EtEx showed a positive correlation (R 2 = 0.979). Thus, it was suggested that WEx and 99%
EtEx contained anti-allergic compounds. However, these results also imply that the decrease in degranulation may be caused by the cytotoxicity of 99% EtEx, not by its anti-allergic effect.
AR mouse model We examined the anti-allergy effects of
WEx and 99% EtEx in AR mice. The sneezing frequency after the fifth i.n. challenge (day 5) was significantly lower in all treatment groups than the control ( Fig. 4A and 4B) . However, the reduction in sneezing frequency was lost on days 6 and 7, and the vascular permeability remained unchanged for all groups (Table 1 ). The absorbance of OVA-specific IgE in the plasma of mice at the experimental end point was significantly lower in all treatment groups than the control (Table 1) . From these results, it was concluded that oral administration of WEx and 99% EtEx 
Discussion
S. tetrandra contains strong biologically active substances such as Tet and Fan. The hot water extract of S. tetrandra suppressed the release of β-hex in RBL-2H3 cells (Asano et al., 2011) .
However, Tet and Fan are only slightly soluble in water. Therefore, we speculated that S. tetrandra contained water-soluble antiallergic compounds.
The main active components of S. tetrandra are alkaloids.
Alkaloids constitute the largest group of nitrogen-containing secondary metabolites in plants (Ernesto et al., 2007) . Most alkaloids in plants bind organic acids and can be extracted with a weak acidic solution (e.g., acetic acid in water, ethanol, or methanol). Tet, Fan, and Cyc can be extracted from S. tetrandra by methanol (Huang et al., 2006) . We removed Tet and Fan from S.
tetrandra by methanol processing because these compounds inhibit histamine release (Nakamura et al., 1992 (Fig. 2) . These data suggest that WEx contains peptides.
Moreover, we developed a simplified separation method for hot water extracts of S. tetrandra.
Tet and Fan are calcium channel blockers and inhibit histamine
release (Ernesto et al., 2007; Nakamura et al., 1992) . However, et al., 2014) , PFNQGTFAS (Ko et al., 2016) , and peptides derived from casein (Tanaka et al., 2012) . Thus, we speculate that WEx peptides may exert antiallergic effects, and that WEx contains safe and water-soluble antiallergic compounds.
There are no reports on the anti-allergic effects of Tet and Fan in vivo. Based on our HPLC results (Fig. 1) , the main compounds in the 99% EtEx were Tet and Fan. AR symptoms and OVAspecific IgE plasma levels were suppressed after treatment with 99% EtEx. Various allergic mediators, which are released from mast and basophilic cells during type I allergic reactions, activate helper T cells (Amin, 2012) . Furthermore, the activated helper T cells induce IgE class switching of B cells. The augmented B cells, through a series of allergic reactions, produce the allergen-specific
IgE. Thus, we suggest that the OVA-specific IgE levels in the In conclusion, the hot water extract of S. tetrandra contains compounds with anti-allergic effects. Tet is a strong calcium channel blocker, while Fan is a calcium channel blocker and HDC inhibitor. The WEx fraction has low toxicity and anti-allergic effects. Moreover, WEx may be a viable option for the treatment of allergic diseases because of its low toxicity and high availability.
Thus, S. tetrandra may be an effective anti-allergic medicine in light of the synergistic anti-allergic effects of WEx and 99% EtEx.
Further study is needed to confirm whether the powder of raw S. tetrandra can be used to treat allergic diseases in humans. Fig. 3 . The inhibitory effects of WEx (A) and 99% EtEx (B) on antigen-stimulated β-hex release and the cell viability of these fractions by MTT assay (C). The values are expressed as mean ± SD, n = 4 _ 6. The statistically significant differences in the β-hex and MTT assays were determined using a one-way ANOVA followed by Dunnett's multiple comparison test. * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. cont. The values are expressed as mean ± SE. n = 4 _ 5. Mice were treated via intragastric administration (Cont group: 100 μL saline, Low-WEx group: 100 μL of 6 mg/mL WEx, High-WEx group: 100 μL of 12 mg/mL WEx, and 99% EtEx group: 100 μL of 0.5 mg/mL 99% EtEx) 30 min prior to the intranasal challenge. The sneezing frequency was recorded during the 15 min after an intranasal injection of 500 μg OVA per 10 μL. The statistically significant differences in sneezing frequency were determined using a repeated two-way ANOVA followed by Bonferroni's multiple comparison test. * p < 0.05, and ** p < 0.01 vs. cont (in the each group), and † p < 0.05, and † † p < 0.01 vs. day 1 (in the each group). Table 1 . Absorbance of OVA-specific IgE at day -1 and the end point, and the vascular permeability at the end point. 1 Values are shown as mean ± SE, n = 4 _ 5. 2 OVA-specific IgE was measured using capture ELISA. The diluted ratio of plasma was 1:40, and the HRP reaction time was for 10 mins at room temperature. 3 The vascular permeability (10 μL plasma equivalent) was calculated as follows: (higher test fluorescence value − higher control fluorescence value)/(plasma fluorescence value). 4 Statistical significance was determined using one-way ANOVA followed by Dunnett's multiple comparison test. * p < 0.05, and ** p < 0.01 vs. cont.
